Obata Life Sciences

Obatala Sciences is a biotechnology company specializing in human-derived biomaterials and tissue engineering platforms to accelerate drug discovery and development. The company's flagship products include ObaGel®, a first-of-its-kind human-derived hydrogel, and ObaCell®, a suite of adipose-derived stem cell products and services. By providing more physiologically relevant human tissue models, such as their 'fat-on-a-chip' technology, Obatala aims to reduce the reliance on animal testing and improve the predictive accuracy of preclinical research. Their solutions are primarily used in the study of metabolic diseases, obesity, diabetes, and tissue regeneration. The company operates as both a product provider and a contract research organization, supporting pharmaceutical partners in developing safer and more effective therapies.